We are live on
!
Find out more
ProShare Advisors Portfolio holdings
AUM
$67.5B
1-Year Est. Return
28.09%
This Quarter
Est. Return
+10.85%
1 Year Est. Return
+28.09%
3 Year Est. Return
+88.43%
5 Year Est. Return
+118.21%
10 Year Est. Return
+464.8%
AUM
$37.6B
AUM Growth
+$4.89B
(+15%)
Cap. Flow
+$2.25B
Cap. Flow
% of AUM
5.98%
Top 10 Holdings %
Top 10 Hldgs %
23.7%
Holding
2,051
New
98
Increased
1,226
Reduced
674
Closed
47
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$202M |
| 2 |
Linde
LIN
|
+$201M |
| 3 |
Apple
AAPL
|
+$192M |
| 4 |
NVIDIA
NVDA
|
+$187M |
| 5 |
Fastenal
FAST
|
+$182M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
WBA
Walgreens Boots Alliance
WBA
|
+$163M |
| 2 |
IBM
IBM
|
+$38.3M |
| 3 |
Target
TGT
|
+$35M |
| 4 |
Sherwin-Williams
SHW
|
+$33.8M |
| 5 |
S&P Global
SPGI
|
+$32.9M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 28.52% |
| 2 | Industrials | 11.95% |
| 3 | Consumer Staples | 11.58% |
| 4 | Consumer Discretionary | 9.61% |
| 5 | Financials | 9.05% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
VMEO
1801
DELISTED
Vimeo
VMEO
| $113K | ﹤0.01% |
27,687
+2,480
| +10% | +$10.6K |
|
1802
Ivanhoe Electric
IE
$1.43B
| $113K | ﹤0.01% |
11,504
+1,043
| +10% | +$8.99K |
|
|
LPRO
1803
Open Lending Corp
LPRO
$373M
| $112K | ﹤0.01% |
17,889
+1,408
| +9% | +$10.4K |
|
1804
Fate Therapeutics
FATE
$281M
| $112K | ﹤0.01% |
15,227
+1,199
| +9% | +$7.42K |
|
1805
FTAI Infrastructure
FIP
$500M
| $112K | ﹤0.01% |
17,783
+1,400
| +9% | +$6.49K |
|
1806
Clear Channel Outdoor Holdings
CCO
$1.23B
| $111K | ﹤0.01% |
67,404
+5,306
| +9% | +$9.06K |
|
1807
Theravance Biopharma
TBPH
$874M
| $110K | ﹤0.01% |
12,219
+508
| +4% | +$4.71K |
|
1808
Lyell Immunopharma
LYEL
$309M
| $109K | ﹤0.01% |
2,449
+208
| +9% | +$8.91K |
|
|
BRY
1809
DELISTED
Berry Corp
BRY
| $109K | ﹤0.01% |
13,546
+1,066
| +9% | +$7.45K |
|
|
RVNC
1810
DELISTED
Revance Therapeutics, Inc.
RVNC
| $108K | ﹤0.01% |
21,904
+1,809
| +9% | +$10.7K |
|
1811
Replimune Group
REPL
$814M
| $108K | ﹤0.01% |
13,186
+1,227
| +10% | +$10.1K |
|
1812
Caribou Biosciences
CRBU
$156M
| $107K | ﹤0.01% |
20,907
+1,704
| +9% | +$10.5K |
|
1813
Prime Medicine
PRME
$533M
| $107K | ﹤0.01% |
15,276
+2,520
| +20% | +$19.1K |
|
|
DHC
1814
Diversified Healthcare Trust
DHC
$2.26B
| $106K | ﹤0.01% |
42,951
+3,380
| +9% | +$9.68K |
|
1815
Conduent
CNDT
$230M
| $105K | ﹤0.01% |
30,927
+2,434
| +9% | +$8.45K |
|
|
LGF.A
1816
DELISTED
Lions Gate Entertainment Corp. Class A Voting Shares
LGF.A
| $104K | ﹤0.01% |
+10,474
| New | +$103K |
|
|
GLDD
1817
DELISTED
Great Lakes Dredge & Dock
GLDD
| $103K | ﹤0.01% |
11,785
+926
| +9% | +$7.62K |
|
|
LAZR
1818
DELISTED
Luminar Technologies
LAZR
| $103K | ﹤0.01% |
3,488
+481
| +16% | +$17.5K |
|
|
OLO
1819
DELISTED
Olo Inc
OLO
| $102K | ﹤0.01% |
18,590
+1,463
| +9% | +$7.99K |
|
1820
Voyager Therapeutics
VYGR
$187M
| $101K | ﹤0.01% |
+10,876
| New | +$91.8K |
|
1821
TETRA Technologies
TTI
$1.23B
| $99.8K | ﹤0.01% |
22,522
+1,772
| +9% | +$7.36K |
|
1822
Adaptive Biotechnologies
ADPT
$3.56B
| $98.2K | ﹤0.01% |
30,577
+2,525
| +9% | +$9.77K |
|
|
NPKI
1823
NPK International
NPKI
$1.21B
| $97.1K | ﹤0.01% |
13,452
+808
| +6% | +$5.28K |
|
1824
Navitas Semiconductor
NVTS
$2.66B
| $97.1K | ﹤0.01% |
20,348
+2,258
| +12% | +$13.3K |
|
1825
MaxCyte
MXCT
$116M
| $96.2K | ﹤0.01% |
22,962
+1,878
| +9% | +$8.82K |
|
Similar funds
ProShare Advisors's Q1 2024 Portfolio in Review
As of Q1 2024, ProShare Advisors held 2,051 positions worth $37.6B, up 15% from $32.7B the previous quarter. Its ten largest holdings account for 24% of the portfolio.
ProShare Advisors deployed $2.25B of net new capital in Q1 2024, opening 98 new positions and adding to 1,226 existing holdings. Its largest new stake was SS&C Technologies: 123,548 shares worth $7.95M.
By sector, the portfolio is most concentrated in Technology at 29% of assets, up from 26% a quarter earlier, followed by Industrials and Consumer Staples.
On the sell side, the largest reduction was Walgreens Boots Alliance, an estimated $163M trimmed.
- ProShare Advisors's largest Q1 2024 buy was SS&C Technologies: 123,548 shares worth $7.95M.
- ProShare Advisors added most to Microsoft in Q1 2024, an estimated $202M increase.
- ProShare Advisors's biggest Q1 2024 reduction was Walgreens Boots Alliance, cutting an estimated $163M.
- ProShare Advisors fully exited Splunk Inc in Q1 2024, selling an estimated $20.4M.
- ProShare Advisors's ten largest holdings make up 24% of its $37.6B portfolio in Q1 2024.
- ProShare Advisors opened 98 new positions and closed 47 in Q1 2024.
- ProShare Advisors's portfolio value rose 15% quarter-over-quarter to $37.6B.
Based on ProShare Advisors's 13F filing for Q1 2024, filed 8 May 2024.